Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Signal Transducer And Activator Of Transcription 3 (STAT3) Inhibitors Pipeline Insights, 2016DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio.
By: DelveInsight Business Research · Comparative study of drugs under development. · Information on several other drugs as well among which 1 are in phase III, 5 in phase II, 3 in phase I, 3 in pre - clinical and 6 in dormant phase. · R&D activities and technologies used along with the pipeline molecules in development. · Information related to collaborations, in-licensing and out-licensing deals. · Stages of development of pipeline molecules. · Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. Report Coverage: · 20+ Products, 15+ Companies Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors - Pipeline Insights, 2016 Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight’ DelveInsight is offering the Report at a price of US 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License. For more information on Pipeline Insight Reports, email at info@delveInsight.com About Us DelveInsight is a leading Business Consulting and Market Research Firm. DelveInsight helps the clients to find answers relevant to their business, facilitating decision-making; End
Account Email Address Account Phone Number Disclaimer Report Abuse Page Updated Last on: Feb 23, 2016
|
|